About the Trial
The ReGen-Brain clinical trial is funded by you, the United States taxpayer, through your support of the National Institute on Aging and by generous support of the Alzheimer’s Drug Discovery Foundation. ReGen-Brain trial is sponsored by the Center for Innovation in Brain Science at the University of Arizona and will be conducted at sites across the United States.
Study Team
-
Dr. Roberta Diaz Brinton, Ph.D., Principal Investigator
Director, University of Arizona, Center for Innovation in Brain Science, Center for Innovation in Brain Science
-
Lon Schneider, M.D., MPI
Professor of Psychiatry and the Behavioral Sciences and Gerontology, Keck School of Medicine at the University of Southern California
-
Dr. Gerson Hernandez, M.D., Co-Investigator
Senior Director, Clinical Trials, University of Arizona, Center for Innovation in Brain Science
-
Claudia Lopez, B.S., Clinical Operations Manager
Clinical Operations Manager, University of Arizona, Center for Innovation in Brain Science
-
Dawn Matthews, M.S., Co-Investigator
Chief Executive Officer, ADMdx
-
Dr. Kathleen Rodgers, Ph.D., MPI
Associate Director, Translational Neuroscience, University of Arizona, Center for Innovation in Brain Science